drugset / Trial / NCT02512029
18F-AV-1451 PET Imaging in TBI
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This study will evaluate imaging characteristics of 18F-AV-1451 in subjects with subacute traumatic brain injury.
Timeline
- Start
- 2015-10
- Primary completion
- 2017-04
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flortaucipir F18 | Diagnostic / imaging agent | 370 mbq | Intravenous |